We are pleased to report Orchard Therapeutics has received EC full (standard) market approval for Libmeldy, an advanced therapy medicine for the treatment of Early-Onset MLD. A decade after the first patient was treated in clinical trials, a one-time treatment with Libmeldy has been shown to preserve motor and cognitive function. Read the full press release
NEWS PAGE